Protocol: - KPV: 200-500 mcg/day oral or subcutaneous - GHK-Cu: 1-2 mg/day subcutaneous or topical - Duration: 6-8 weeks Best for: Inflammatory arthritis, autoimmune joint conditions, multi-joint inflammation in older adults
Not affiliated: PlexusDx has no relationship with Hers or Mochi Health and reviewed both independently
CagriSema is proven to beat tirzepatide because the weight loss is higher. It is not proven to beat anything relative to tirzepatide
Lorenzo V, Torres A, Salido E (2014) Primary hyperoxaluria
Despite extensive research, some scientists classify curcumin as a pan-assay interference compound (PAIN), which challenges its validity as a metabolic panacea (IMPS) or as a suitable lead compound (Nelson et al., 2017)
IV infusions take longer (about 45 min) and administer higher doses of vitamins and minerals